Oppenheimer Asset Management Inc. Reduces Stock Holdings in Privia Health Group, Inc. (NASDAQ:PRVA)

Oppenheimer Asset Management Inc. lowered its position in shares of Privia Health Group, Inc. (NASDAQ:PRVA) by 1.6% in the third quarter, HoldingsChannel.com reports. The fund owned 241,199 shares of the company’s stock after selling 3,938 shares during the quarter. Oppenheimer Asset Management Inc.’s holdings in Privia Health Group were worth $4,392,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in PRVA. First Light Asset Management LLC acquired a new stake in Privia Health Group during the 1st quarter worth about $21,620,000. Millennium Management LLC lifted its holdings in shares of Privia Health Group by 2,994.2% in the 2nd quarter. Millennium Management LLC now owns 1,138,526 shares of the company’s stock valued at $19,788,000 after buying an additional 1,101,730 shares during the period. BlackBarn Capital Partners LP lifted its holdings in shares of Privia Health Group by 100.0% in the 2nd quarter. BlackBarn Capital Partners LP now owns 400,000 shares of the company’s stock valued at $6,952,000 after buying an additional 200,000 shares during the period. Dimensional Fund Advisors LP lifted its holdings in shares of Privia Health Group by 18.4% in the 2nd quarter. Dimensional Fund Advisors LP now owns 1,118,619 shares of the company’s stock valued at $19,441,000 after buying an additional 173,934 shares during the period. Finally, Sei Investments Co. lifted its holdings in shares of Privia Health Group by 50.7% in the 1st quarter. Sei Investments Co. now owns 457,880 shares of the company’s stock valued at $8,970,000 after buying an additional 154,044 shares during the period. Institutional investors and hedge funds own 94.48% of the company’s stock.

Privia Health Group Trading Down 2.3 %

NASDAQ:PRVA opened at $21.20 on Friday. Privia Health Group, Inc. has a 12 month low of $15.92 and a 12 month high of $24.30. The stock has a 50 day moving average of $18.71 and a two-hundred day moving average of $18.49. The firm has a market cap of $2.54 billion, a P/E ratio of 212.00, a price-to-earnings-growth ratio of 5.07 and a beta of 0.76.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on PRVA shares. Royal Bank of Canada reissued an “outperform” rating and issued a $28.00 price objective on shares of Privia Health Group in a report on Wednesday, August 14th. Truist Financial boosted their price objective on Privia Health Group from $24.00 to $27.00 and gave the company a “buy” rating in a report on Friday, November 8th. KeyCorp initiated coverage on Privia Health Group in a report on Friday, October 11th. They issued an “overweight” rating and a $23.00 price target for the company. Robert W. Baird upped their price target on Privia Health Group from $23.00 to $24.00 and gave the stock an “outperform” rating in a report on Monday, August 26th. Finally, Barclays upped their price target on Privia Health Group from $19.00 to $21.00 and gave the stock an “equal weight” rating in a report on Friday, November 8th. Two equities research analysts have rated the stock with a hold rating, twelve have assigned a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat.com, Privia Health Group has a consensus rating of “Buy” and an average price target of $25.07.

Insiders Place Their Bets

In other news, CEO Parth Mehrotra sold 135,142 shares of the company’s stock in a transaction that occurred on Tuesday, September 10th. The stock was sold at an average price of $18.50, for a total value of $2,500,127.00. Following the completion of the sale, the chief executive officer now directly owns 247,771 shares in the company, valued at $4,583,763.50. This represents a 35.29 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 14.20% of the stock is owned by company insiders.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.